N-methyl-4-bromo-2-fluoro-benzamide is an intermediate in the synthesis of MDV3100 (M199800). It is an androgen receptor antagonist, which can block the binding of androgen and androgen receptor, and prevent nuclear translocation and recruitment of coactivators. Ligand receptor complex. N-methyl-4-bromo-2-fluoro-benzamide is used as an amide organic compound, which can be used as a pharmaceutical intermediate.